Immutep IMMP
NASDAQ IMMP
$4.54 -0.11 (-2.37%)
At close: Oct 1, 2026 · 4:00 PM EDT

Immutep (IMMP) Non Operating Interest Expenses (2015 - 2016)

Updated

Immutep (IMMP) reported Non Operating Interest Expenses of -$48,162 for the year ended Jun 30, 2026, compared with -$23,746 a year earlier.

Analysis

Immutep (IMMP) Non Operating Interest Expenses (2015 - 2016) Analysis & Trends

Dating back to the year ended Jun 30, 2009, Immutep's Non Operating Interest Expenses record includes 12 years.

  • The figure for the year ended Jun 30, 2026 ranks as the lowest annual Non Operating Interest Expenses since the year ended Jun 30, 2022.
  • According to Business Quant data, Non Operating Interest Expenses came in at -$23,746 in the year ended Jun 30, 2025, -$20,162 in the year ended Jun 30, 2024, -$13,635 in the year ended Jun 30, 2023 and -$66.2 billion in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immutep 33.95 Mn 33.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 6,122.21
Jun 30, 2015 20,826.38
API Access

Immutep Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IMMP&period=max&api_key=YOUR_API_KEY